DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20181190

A questionnaire-based study on knowledge and attitude towards counterfeit medication among the doctors in tertiary care hospital

Vijay Yadav, Navin Budania, Arka Mondal, Naveen Kumar, Ritesh Kumar, Vinod Kumar Bhardwaj, Vijay Kumar Chhockra, Nadish Garg, Aditi Punia, Priyamvada Sharma

Abstract


Background: Counterfeit drugs are a global problem and suffered almost all developing and developed countries worldwide. In India, it is a major problem which results life threatening issues as well as financial loss on health system. So, we conducted a cross sectional questionnaire-based study on knowledge and exposure to counterfeit drugs of doctors at SHKM Govt. Medical College, Nuh, Haryana, India.

Methods: A structured questionnaire was distributed to 100 registered doctors. The questionnaire was based on knowledge, attitude and its consequence on the heath system by the practices of counterfeit medication.

Results: There were Twenty questionnaires excluded from the study due to incomplete information. Only 57.77% (46/80) subjects having the knowledge of questionnaire correct meaning of counterfeit drug. However, almost 90% (72/80) subjects were aware about its dangerous effects. More than 50% of the subjects have suggested that modern technology is capable to control counterfeiting of the medicine.

Conclusions: Counterfeit drugs create a people health hazard and waste to consumer income. The proper knowledge, awareness and modern technological approaches are the devices may helpful in diminution of counterfeit medication practices.

 


Keywords


Counterfeit drug, Doctors, Medication

Full Text:

PDF

References


Geneva, Switzerland: Department of Essential Drugs and Other Medicines, WHO; 1999. World Health Organization. Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs. Available at: http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM99.1.pdf .

World Health Organization. General Information on Counterfeit Medicines. [Last accessed on 2013 May 19]. Available at: http://www.who.int/medicines/services/counterfeit/overview/en

Counterfeit Drugs Kill, World Health Organization. Available at: http://www.who.int/impact/FinalBrochureWHA2008a.pdf

Bate R. Washington DC. American Enterprise Institute. Making a killing. The deadly implications of the counterfeit drug trade; 2008.

Sammons HM, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatrics Open. 2017;1:e000007.

Shah NA, Bhagya M, Sattigeri, Nirav NP, Haresh AD. Counterfeit drugs in India: significance and impact on pharmacovigilance. Int J Res Med Sci. 2015;3:2156-60.

Chika FU, Alphonsus CO, Obiageli FE, Maureen NA, Andrew UU, Samuel OI. Factors associated with drug counterfeit in Nigeria: A twelve-year review. British Journal of Medicine & Medical Research. 2016;12:1-8.

Golocorbin KS, Mikov M. Counterfeit drugs as a gobal threat to health. Med Pregl. 2011;64:285-90.

Nagaraj A, Tambi S, Biswas G, Ganta S, Kumawat H, Mathur G. Counterfeit medication: Perception of doctors and medical wholesale distributors in western India. J Int Soc Prev Community Dent. 2015;5:S7-S11.

Mackey TK, Cuomo R, Guerra C, Liang BA. After counterfeit Avastin®--what have we learned and what can be done? Nat. Rev Clin Oncol. 2015;12(5):302-08.

Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm. Sci. 2011;100:4571-79.

Bansal D, Malla S, Gudala K, Tiwari P. Anti-counterfeit technologies: a pharmaceutical industry perspective. Sci Pharm. 2013;81:1-13.

Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: asystematic review of the literature. BMJ Open. 2013;3;1-7.